Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis

ObjectiveTo compare the short-term efficacy and safety of efgartigimod versus intravenous immunoglobulin (IVIg) in patients with impending myasthenic crisis (IMC).MethodsThis single-center, randomized, open-label, prospective comparative cohort study included 38 acetylcholine receptor antibody–posit...

Description complète

Détails bibliographiques

Auteurs principaux:	Ning Li, Yinghui Zhang, Lu Liu, Yanzi Jin, Li Zhao, Shuhui Zhu, Yating Li, Boya Ma, Jiahui Peng, Juan Yang, Qian Li, Xiao Yang
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-03-01
Collection:	Frontiers in Immunology
Sujets:	crisis efgartigimod FcRn antagonist immunoglobulin impending intravenous
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1760953/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!